Sorry, you need to enable JavaScript to visit this website.

Sign Up For Mailing List Button

Donate to Genetic Alliance

Disease Search Button

APPENDIX A. Federal Regulations

Facebook icon
Google+ icon
Twitter icon
LinkedIn icon
Del.icio.us icon
Digg icon
  1. 32 CFR 219: Protection of Human participants (the Common Rule)
  2. 45 CFR 46: Subpart B: Additional Protections Pertaining to Research, Development, and Related Activities Involving Fetuses, Pregnant Women, and Human In Vitro Fertilization; Subpart C: Additional      Protections Pertaining to Biomedical and Behavioral Research Involving Prisoners as Participants; and Subpart D: Additional Protections for Children involved as Participants in Research
  3. 21 CFR 50: Protection of Human participants (FDA)
  4. 21CFR 54: Financial Disclosures by Clinical Investigators (FDA)
  5. 21 CFR 56: Institutional Review Boards (FDA)
  6. 21 CFR 312: Investigational New Drug (IND) Application (FDA)
  7. 21 CFR 812: Investigational Device Exemption (IDE) (FDA)
  8. 45 CFR 160 & 164: Health Insurance Portability and Accountability Act (HIPAA) of 1996 (http://www.hhs.gov/ocr/hipaa/)
Twitter icon
Facebook icon
LinkedIn icon
Google+ icon
YouTube icon
RSS icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.